Neothetics, Inc. 4
4 · Neothetics, Inc. · Filed Mar 6, 2017
Insider Transaction Report
Form 4
Neothetics, Inc.NEOT
Knudson Susan A.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-03-02+100,000→ 100,000 totalExercise: $1.43Exp: 2027-03-02→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1](i) One half of the option shares vest upon receipt and completed analysis of LIPO-202 CL-31 trial data and (ii) the remaining one half of the option shares vest at the earlier of (a) 12/31/2017 or (b) upon the event of a change in control.